Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Ang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Medical Journal of Malaysia|July 30, 2020
Misdiagnosis of community-acquired pneumonia in patients admitted to respiratory wards, Penang General HospitalC S Ang, K M Kelvin Beh, L J Yeang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumorsW T Lim, E H Tan, C K Toh, et al.
Yearbook of Medical Informatics|September 23, 2011
The role of social media for patients and consumer health. Contribution of the IMIA Consumer Health Informatics Working GroupA Y S Lau, K A Siek, L Fernandez-Luque, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancerHenry L Gomez, Dinesh C Doval, Miguel A Chavez, et al.
Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.
International Archives of Allergy and Immunology|March 3, 2012
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper, J Bousquet, J M Anto, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Medical Journal of Malaysia|July 30, 2020
Misdiagnosis of community-acquired pneumonia in patients admitted to respiratory wards, Penang General HospitalC S Ang, K M Kelvin Beh, L J Yeang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumorsW T Lim, E H Tan, C K Toh, et al.
Yearbook of Medical Informatics|September 23, 2011
The role of social media for patients and consumer health. Contribution of the IMIA Consumer Health Informatics Working GroupA Y S Lau, K A Siek, L Fernandez-Luque, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2008
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancerHenry L Gomez, Dinesh C Doval, Miguel A Chavez, et al.
Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.
International Archives of Allergy and Immunology|March 3, 2012
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper, J Bousquet, J M Anto, et al.
Pageof 2